Abeer A sharfalddin

Dr. Abeer A sharfalddin

King Abdulaziz University, Jeddah, Makkah al Mukarramah, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2021 in Polysaccharides
Verified
Journal Article
Open access
PDF file
MJMariusz jaremko
Mariusz jaremko
QAQana Alsulami
Qana Alsulami
ASAbeer A sharfalddin
Abeer A sharfalddin
EGEMAM Fikry Gomaa
EMAM Fikry Gomaa
FMFouzi Mouffouk
Fouzi Mouffouk
MJMariusz jaremko
Mariusz jaremko
Due to their unique structural, physical and chemical properties, cyclodextrins and their derivatives have been of great interest to scientists and researchers in both academia and industry for over a century. Many of the industrial applications of cyclodextrins have arisen from their ability to encapsulate, either partially or fully, other molecules, especially organic compounds. Cyclodextrins are non-toxic oligopolymers of glucose that help to increase the solubility of organic compounds with poor aqueous solubility, can mask odors from foul-smelling compounds, and have been widely studied in the area of drug delivery. In this review, we explore the structural and chemical properties of cyclodextrins that give rise to this encapsulation (i.e., the formation of inclusion complexes) ability. This review is unique from others written on this subject because it provides powerful insights into factors that affect cyclodextrin encapsulation. It also examines these insights in great detail. Later, we provide an overview of some industrial applications of cyclodextrins, while emphasizing the role of encapsulation in these applications. We strongly believe that cyclodextrins will continue to garner interest from scientists for many years to come, and that novel applications of cyclodextrins have yet to be discovered.

6 December 2022 in Inorganics
Verified
Journal Article
Open access
PDF file
ASAbeer A sharfalddin
Abeer A sharfalddin
IAInas Al-Younis
Inas Al-Younis
Hamdoon Abdelhamid MohammedHamdoon Abdelhamid Mohammed
Hamdoon Abdelhamid Mohammed
MDManel Dhahri
Manel Dhahri
FMFouzi Mouffouk
Fouzi Mouffouk
AEAbdul-Hamid Emwas
Abdul-Hamid Emwas
Vanadium is a hard, silver-grey transition metal found in at least 60 minerals and fossil fuel deposits. Its oxide and other vanadium salts are toxic to humans, but the toxic effects depend on the vanadium form, dose, exposure duration, and route of intoxication. Vanadium is used by some life forms as an active center in enzymes, such as the vanadium bromoperoxidase of ocean algae and nitrogenases of bacteria. The structure and biochemistry of vanadate resemble those of phosphate, hence vanadate can be regarded as a phosphate competitor in a variety of biochemical enzymes such as kinases and phosphatases. In this review, we describe the biochemical pathways regulated by vanadium compounds and their potential therapeutic benefits for a range of disorders including type 2 diabetes, cancer, cardiovascular disease, and microbial pathology.

3 November 2020 in Applied Organometallic Chemistry
Verified
Journal Article
Open access
PDF file
ASAbeer A sharfalddin
Abeer A sharfalddin
AEAbdul-Hamid Emwas
Abdul-Hamid Emwas
MJMariusz jaremko
Mariusz jaremko
Mostafa A. HussienMostafa A. Hussien
Mostafa A. Hussien
6‐mercaptopurine (6‐MP) is used for treating various cancers and autoimmune disorders. A few examples of transition metal complexes of 6‐MP have been shown to enhance its anticancer activity, but many remain untested. We isolated five highly stable and colored metal complexes of 6‐MP and confirmed their structures by elemental analysis, spectral, and thermal techniques. Infrared (IR) spectra revealed that 6‐MP is a bidentate ligand that interacts through sulfur and pyrimidine nitrogen in a 1:2 (M:L) molar ratio. The magnetic susceptibility and electron paramagnetic resonance (EPR) spectra for the Cu(II) complex revealed an octahedral arrangement around the metal ion with strong covalent bonding. The fully optimized geometries of the metal structures obtained using density function theory (DFT)/B3LYP calculations were used to verify the structural and biological features. DNA titration revealed that the octahedral Cu(II) complex has a critical binding constant value ofKb= 8 × 105. Docking studies using three different cancer protein receptors were used to predict the biological applications of the synthesized drug‐metal complexes. Finally, cytotoxicity assays against a myeloma cancer cell line (MM) and a colon cancer cell line (Caco‐2) revealed favorable anticancer activity for the copper complex, exceeding that of the gold‐standard chemotherapeutic cisplatin.

12 May 2021 in New Journal of Chemistry
Verified
Journal Article
Open access
PDF file
ASAbeer A sharfalddin
Abeer A sharfalddin
AEAbdul-Hamid Emwas
Abdul-Hamid Emwas
MJMariusz jaremko
Mariusz jaremko
Mostafa A. HussienMostafa A. Hussien
Mostafa A. Hussien
Thiamphenicol (TM) is an antimicrobial drug and a methyl-sulfonyl analogue of chloramphenicol. New metal complexes of TM with Zn(II), Cu(II), Ni(II), Co(II) and Fe(II) were synthesized and characterized using elemental analyses, infrared (IR) and proton nuclear magnetic resonance spectroscopy (1H-NMR), magnetic susceptibility, electron paramagnetic resonance (EPR) spectroscopy, and thermogravimetric analysis (TGA). The IR spectra revealed coordination of the deprotonated ligand to the metal through one oxygen and the nitrogen atom of the amide group. Moreover, EPR analysis of the Cu(II) solid sample indicated a distorted tetrahedral structure with a negligible exchange interaction between the Cu(II) ions. The UV-vis spectral results from the Co(II) and Fe(II) complexes showed a distorted tetrahedral geometric arrangement for both compounds. The DFT calculation approach was used to study the nature of the interaction between the metal ions and the ligand where the molecular stability and bond strengths were evaluated by Natural Bond Orbital (NBO) and quantum parameters. The biological activity of the metal complexes was investigated by several different bioassays. The DNA binding constant Kb showed an intercalation binding mode for both the free drug and the metal compounds. An in vitro protein (HSA) binding study showed binding with TM–Zn Kb = 9.87 × 105 M−1. The cytotoxic activity of each divalent complex was tested against two cell lines: (1) a human colon carcinoma (HCT-116) cell line and (2) a human breast carcinoma (MCF-7) tumor cell line and demonstrated anti-cancer cell activities. Molecular docking was utilized to explain the biological inhibition of the Cu(II) and Zn(II) complexes.

1 September 2021 in Ageing Research Reviews
Verified
Journal Article
Open access
AEAbdul-Hamid Emwas
Abdul-Hamid Emwas
MAMawadda Alghrably
Mawadda Alghrably
MDManel Dhahri
Manel Dhahri
ASAbeer A sharfalddin
Abeer A sharfalddin
RARawiah Alsiary
Rawiah Alsiary
JLJoanna Izabela Lachowicz
Joanna Izabela Lachowicz
Conformational diseases are caused by the aggregation of misfolded proteins. The risk for such pathologies develops years before clinical symptoms appear, and is higher in people with alpha-1 antitrypsin (AAT) polymorphisms. Thousands of people with alpha-1 antitrypsin deficiency (AATD) are underdiagnosed. Enemy-aggregating proteins may reside in these underdiagnosed AATD patients for many years before a pathology for AATD fully develops. In this perspective review, we hypothesize that the AAT protein could exert a new and previously unconsidered biological effect as an endogenous metal ion chelator that plays a significant role in essential metal ion homeostasis. In this respect, AAT polymorphism may cause an imbalance of metal ions, which could be correlated with the aggregation of amylin, tau, amyloid beta, and alpha synuclein proteins in type 2 diabetes mellitus (T2DM), Alzheimer's and Parkinson's diseases, respectively.

29 September 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
HHHanan B. Howsaui
Hanan B. Howsaui
ASAbeer A sharfalddin
Abeer A sharfalddin
MAMagda Abdellattif
Magda Abdellattif
ABAmal Basaleh
Amal Basaleh
Mostafa A. HussienMostafa A. Hussien
Mostafa A. Hussien
In the search for novel anticancer complex, transition metal complexes of Schiff base derived from 2-aminopyrazine and salicylaldehyde were successfully synthesized and characterized based on elemental analyses, spectroscopic and thermal analysis. The IR spectra showed the ligand is a tridentate chelator with O, N and N atoms. donor sites in the Zn(II), Co(II), Ni(II), and Mn(II) complexes. Contrary, it behaved a bidentate chelator in the Cu complex by O and N. Molar ratio data revealed that the ligand to metal ratio was 1:2 for Co(II) Cu(II) and Zn(II) while it was 1:1 for Mn(II) and Ni(II) complexes. The obtained complexes have the formulae [M(L)2] (where M = Co(II) and Zn(II), [M(L)Cl(2H2O)]·H2O (where M = Ni(II) and Mn(II) were octahedral geometry). The computational studies were performed by DFT calculations to compare the optimized geometries with the experimental values. The interaction of these complexes with calf thymus DNA (CT-DNA) was investigated by UV-Vis spectroscopic technique. Molecular docking studies were against three protein cancer to investigate the binding ability of the new compounds. The anticancer activity was studied with different cell lines and the IC50 of the Cu(II) complex for (HOP-62) showed a practical result. The LD50 values of Zn(II) and Co(II) complexes showed that they are non-toxic at doses up to 370 mg/kg.